MRNA

Moderna Inc.

Price

$52.84

return (12m)

p/e

-8.66

p/bv

3.73

DIVIDEND YIELD

0.00%

MRNA price

Moderna

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MRNA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals MRNA

Valuation

P/E

-8.66

Sector -4.15

Industry -4.15

P/BV

3.73

Sector 2.06

Industry 2.06

P/Revenue (PSR)

12.55

Sector -4.16

Industry -4.16

EV/EBITDA

-18.32

Sector -241.86

Industry -241.86

EV/EBIT

-17.50

Sector -671.75

Industry -671.75

P/EBITDA

-9.61

Sector -4.30

Industry -4.30

P/EBIT

-8.89

Sector -4.35

Industry -4.35

P/Total Assets

2.41

Sector 1.46

Industry 1.46

P/Net Current Assets

16.37

Sector -12.67

Industry -12.67

P/Working Capital

8.20

Sector -12.58

Industry -12.58

EPS

-8.09

Sector -2.19

Industry -2.19

BVPS

18.75

Sector 1.92

Industry 1.92

Efficiency

Gross Margin

21.37%

Sector 36.44%

Industry 36.44%

EBITDA Margin

-323.39%

Sector -16,748.51%

Industry -16,748.51%

EBIT Margin

-338.56%

Sector -4,256,846.44%

Industry -4,256,846.44%

Operating Margin

-100.00%

Sector -38.78%

Industry -38.78%

Net Profit Margins

-100.00%

Sector -39.93%

Industry -39.93%

Asset Turnover

0.03

Sector 0.03

Industry 0.03

Profitability

ROE

-43.12%

Sector -67.01%

Industry -67.01%

ROA

-27.80%

Sector -66.28%

Industry -66.28%

ROIC

-81.50%

Sector -2,917.75%

Industry -2,917.75%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.41

Sector 2.90

Industry 2.90

Net Debt / EBITDA

3.67

Sector -12,252,405.04

Industry -12,252,405.04

Net Debt / EBIT

3.50

Sector -3.79

Industry -3.79

Net Debt / Equity

-0.62

Sector -33,290.93

Industry -33,290.93

Gross Debt / Equity

0.08

Sector 0.00

Industry 0.00

Equity/Assets

0.64

Sector 0.42

Industry 0.42

Liabilities/Assets

0.36

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-34.10%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals MRNA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MRNA Moderna Inc.	$52.84	101.68%	0.00%	-8.66	3.73	-43.12%	-100.00%
AZN AstraZeneca PLC	$204.64	53.45%	1.89%	25.20	5.52	21.93%	17.19%
JNJ Johnson & Johnson	$240.16	62.69%	2.08%	28.83	0.00	-%	21.48%
ABEO Abeona Therapeutics Inc.	$5.19	12.83%	0.00%	6.09	2.78	45.63%	100.00%
ABUS Arbutus Biopharma Corporation	$4.35	38.54%	0.00%	5.66	3.50	61.77%	83.94%
PFE Pfizer Inc.	$27.11	32.71%	6.97%	18.76	1.55	8.29%	11.83%
NBIX Neurocrine Biosciences Inc.	$130.81	43.95%	0.00%	25.46	5.00	19.62%	21.55%
ABBV AbbVie Inc.	$210.26	25.08%	2.61%	125.53	-69.01	-54.98%	5.79%
ACAD ACADIA Pharmaceuticals Inc.	$22.02	51.03%	0.00%	11.55	3.48	30.10%	34.30%
ADMA ADMA Biologics Inc.	$10.49	-45.93%	0.00%	12.58	5.33	42.37%	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MRNA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Moderna

Moderna Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

10 years

Founded: 2016

2018

Time since IPO - 8 years

1.300

Employees

Moderna Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $27.66 billion, with shareholders equity totaling $7.41 billion.

The company employs approximately 1.300 people and operates in the Healthcare sector, within the Biotecnologia industry.

Over the past 12 months, Moderna Inc. reported $2.20 billion in revenue, generating net income of $-3.19 billion.

Key financial metrics include a P/E ratio of -8.66, a price-to-book (P/B) ratio of 3.73, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MRNA.

Market cap

$27.66 billion

Net worth

$7.41 billion

$7,408,000,000.00

Assets

$11.49 billion

$11,488,000,000.00

Total Shares Outstanding

395.00 million

395,000,000

Average Daily Trading Volume

$7.61 million

$7,612,175.48

Sector

Healthcare

Industry

Biotecnologia

MRNA

revenue by Business Segment Moderna

MRNA revenue and profits

Financial Results MRNA

DRAG THE FRAME TO SEE MORE DATA

MRNA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$862.96 22,54% (12M)

P/E

21.66

0.39%

ROE

-570.98%

P/BV

-123.68

CAH - Cardinal Health

$214.95 38,63% (12M)

P/E

34.90

0.89%

ROE

-58.20%

P/BV

-20.31

JNJ - Johnson & Johnson

$240.16 47,25% (12M)

P/E

28.83

2.08%

ROE

P/BV

0.00

MRK - Merck & Co.

$119.96 46,43% (12M)

P/E

35.53

2.62%

ROE

19.45%

P/BV

6.91

AZN - AstraZeneca

$204.64 40,78% (12M)

P/E

25.20

1.89%

ROE

21.93%

P/BV

5.52

ABBV - AbbVie

$210.26 15,08% (12M)

P/E

125.53

2.61%

ROE

-54.98%

P/BV

-69.01

NVO - Novo Nordisk

$39.32 --40,26% (12M)

P/E

11.83

3.68%

ROE

60.40%

P/BV

7.14